Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ambrx Biopharma Inc ADR stock

Learn how to easily invest in Ambrx Biopharma Inc ADR stock.

Ambrx Biopharma Inc ADR is a biotechnology business based in the US. Ambrx Biopharma Inc ADR shares (AMAM) are listed on the NYSE and all prices are listed in US Dollars. Ambrx Biopharma Inc ADR employs 81 staff and has a trailing 12-month revenue of around $5.2 million.

How to buy shares in Ambrx Biopharma Inc ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMAM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Ambrx Biopharma Inc ADR stock price (NYSE: AMAM)

Use our graph to track the performance of AMAM stocks over time.

Ambrx Biopharma Inc ADR shares at a glance

Information last updated 2022-09-25.
Latest market close$1.07
52-week range$1.02 - $14.82
50-day moving average $2.03
200-day moving average $4.18
Wall St. target price$6.67
PE ratio 0.1636
Dividend yield $0 (0%)
Earnings per share (TTM) $6.47

Buy Ambrx Biopharma Inc ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ambrx Biopharma Inc ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ambrx Biopharma Inc ADR price performance over time

Historical closes compared with the close of $1.07 from 2022-09-26

1 week (2022-09-20) -6.14%
1 month (2022-08-26) -43.39%
3 months (2022-06-28) -59.47%
6 months (2022-03-28) -76.48%
1 year (2021-09-28) -92.23%
2 years (2020-09-24) N/A
3 years (2019-09-24) N/A
5 years (2017-09-24) N/A

Is Ambrx Biopharma Inc ADR stock undervalued or overvalued?

Valuing Ambrx Biopharma Inc ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ambrx Biopharma Inc ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ambrx Biopharma Inc ADR's P/E ratio

Ambrx Biopharma Inc ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Ambrx Biopharma Inc ADR shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Ambrx Biopharma Inc ADR's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.

    Ambrx Biopharma Inc ADR financials

    Revenue TTM $5.2 million
    Gross profit TTM $7.5 million
    Return on assets TTM -24.66%
    Return on equity TTM -54.12%
    Profit margin 0%
    Book value $3.67
    Market capitalisation $40.9 million

    TTM: trailing 12 months

    Ambrx Biopharma Inc ADR share dividends

    We're not expecting Ambrx Biopharma Inc ADR to pay a dividend over the next 12 months.

    Ambrx Biopharma Inc ADR overview

    Ambrx Biopharma Inc. , a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer. The company is also developing two earlier-stage product candidates, including ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for the treatment of prostate cancer and other solid tumors; and ARX305, an anti-CD70 ADC in investigational new drug-enabling studies for the treatment of renal cell carcinoma and other cancers. In addition, it is developing other multiple product candidates targeting immuno-oncology applications, which include ARX822, a fab-small molecule bispecific that is in preclinical development for cancers; and ARX102, an immuno-oncology IL-2 pathway agonist to stimulate the patient's own immune system by targeting the ß and gamma receptors on the cytotoxic T cell. Ambrx Biopharma Inc. has collaborations with Bristol Myers Squibb Company; AbbVie Inc.

    Frequently asked questions

    What percentage of Ambrx Biopharma Inc ADR is owned by institutions?
    Currently 50.975% of Ambrx Biopharma Inc ADR shares are held by institutions.
    How many people work for Ambrx Biopharma Inc ADR?
    Latest data suggests 81 work at Ambrx Biopharma Inc ADR.
    When does the fiscal year end for Ambrx Biopharma Inc ADR?
    Ambrx Biopharma Inc ADR's fiscal year ends in December.
    Where is Ambrx Biopharma Inc ADR based?
    Ambrx Biopharma Inc ADR's address is: 10975 North Torrey Pines Road, La Jolla, CA, United States, 92037
    What is Ambrx Biopharma Inc ADR's ISIN number?
    Ambrx Biopharma Inc ADR's international securities identification number is: US02290A1025

    More guides on Finder

    Ask an Expert

    You are about to post a question on finder.com:

    • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
    • finder.com is a financial comparison and information service, not a bank or product provider
    • We cannot provide you with personal advice or recommendations
    • Your answer might already be waiting – check previous questions below to see if yours has already been asked

    Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

    By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

    Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
    Go to site